Vir Biotechnology IncNASDAQ:VIR
- LAST PRICE7.5600
- TODAY'S CHANGE (%)0.0700 (0.9346%)
- Bid / Lots7.1400/ 1
- Ask / Lots7.5600/ 3
- Open / Previous Close7.4400 / 7.4900
- Day Range
- 52 Week Range
- Volume1,087,154
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VIR |
|---|---|---|
| 09:32 ET | 6723 | 7.44 |
| 09:34 ET | 2470 | 7.38 |
| 09:36 ET | 7573 | 7.38 |
| 09:38 ET | 1561 | 7.3465 |
| 09:39 ET | 2300 | 7.32 |
| 09:41 ET | 6999 | 7.305 |
| 09:43 ET | 1900 | 7.3 |
| 09:45 ET | 7411 | 7.25 |
| 09:48 ET | 6257 | 7.27 |
| 09:50 ET | 900 | 7.29 |
| 09:52 ET | 300 | 7.3 |
| 09:56 ET | 200 | 7.29 |
| 09:57 ET | 2385 | 7.285 |
| 09:59 ET | 700 | 7.295 |
| 10:01 ET | 4776 | 7.31 |
| 10:03 ET | 400 | 7.305 |
| 10:06 ET | 2776 | 7.31 |
| 10:08 ET | 3646 | 7.28 |
| 10:10 ET | 2893 | 7.27 |
| 10:12 ET | 39847 | 7.21 |
| 10:14 ET | 1333 | 7.205 |
| 10:15 ET | 7277 | 7.17 |
| 10:17 ET | 7170 | 7.17 |
| 10:19 ET | 980 | 7.16 |
| 10:21 ET | 10676 | 7.17 |
| 10:24 ET | 3550 | 7.18 |
| 10:26 ET | 2250 | 7.21 |
| 10:28 ET | 1100 | 7.2 |
| 10:30 ET | 1415 | 7.17 |
| 10:32 ET | 1784 | 7.18 |
| 10:33 ET | 1275 | 7.19 |
| 10:35 ET | 375 | 7.222 |
| 10:37 ET | 2984 | 7.22 |
| 10:39 ET | 2556 | 7.23 |
| 10:42 ET | 1000 | 7.21 |
| 10:44 ET | 2448 | 7.21 |
| 10:46 ET | 2197 | 7.21 |
| 10:48 ET | 2368 | 7.19 |
| 10:50 ET | 1299 | 7.17 |
| 10:51 ET | 3032 | 7.17 |
| 10:53 ET | 500 | 7.175 |
| 10:55 ET | 2700 | 7.17 |
| 10:57 ET | 5845 | 7.17 |
| 11:00 ET | 200 | 7.17 |
| 11:02 ET | 2154 | 7.1797 |
| 11:04 ET | 2193 | 7.1699 |
| 11:06 ET | 4186 | 7.15 |
| 11:08 ET | 5138 | 7.14 |
| 11:09 ET | 542 | 7.13 |
| 11:11 ET | 600 | 7.125 |
| 11:13 ET | 3071 | 7.17 |
| 11:15 ET | 4213 | 7.2 |
| 11:18 ET | 4010 | 7.18 |
| 11:20 ET | 3008 | 7.2 |
| 11:24 ET | 300 | 7.19 |
| 11:27 ET | 1100 | 7.185 |
| 11:29 ET | 1217 | 7.2 |
| 11:31 ET | 2329 | 7.2 |
| 11:33 ET | 1711 | 7.23 |
| 11:36 ET | 3265 | 7.2344 |
| 11:38 ET | 5729 | 7.2601 |
| 11:40 ET | 886 | 7.27 |
| 11:42 ET | 605 | 7.28 |
| 11:44 ET | 6452 | 7.2708 |
| 11:45 ET | 463 | 7.27 |
| 11:47 ET | 400 | 7.28 |
| 11:49 ET | 100 | 7.28 |
| 11:51 ET | 200 | 7.27 |
| 11:54 ET | 10074 | 7.33 |
| 11:56 ET | 9672 | 7.3405 |
| 11:58 ET | 23365 | 7.34 |
| 12:00 ET | 1048 | 7.375 |
| 12:02 ET | 1800 | 7.38 |
| 12:03 ET | 2469 | 7.385 |
| 12:05 ET | 645 | 7.39 |
| 12:07 ET | 2775 | 7.415 |
| 12:09 ET | 2801 | 7.42 |
| 12:12 ET | 1030 | 7.42 |
| 12:14 ET | 2068 | 7.43 |
| 12:16 ET | 1717 | 7.43 |
| 12:18 ET | 3983 | 7.42 |
| 12:20 ET | 3737 | 7.4 |
| 12:21 ET | 3600 | 7.402 |
| 12:23 ET | 904 | 7.415 |
| 12:25 ET | 1927 | 7.41 |
| 12:27 ET | 100 | 7.4064 |
| 12:30 ET | 1389 | 7.4 |
| 12:32 ET | 100 | 7.405 |
| 12:34 ET | 9967 | 7.34 |
| 12:36 ET | 2148 | 7.34 |
| 12:38 ET | 1843 | 7.34 |
| 12:39 ET | 300 | 7.34 |
| 12:41 ET | 1429 | 7.32 |
| 12:43 ET | 1710 | 7.3316 |
| 12:45 ET | 1338 | 7.333 |
| 12:48 ET | 6926 | 7.33 |
| 12:50 ET | 2422 | 7.33 |
| 12:54 ET | 2360 | 7.36 |
| 12:56 ET | 578 | 7.37 |
| 12:57 ET | 2366 | 7.36 |
| 12:59 ET | 1549 | 7.35 |
| 01:01 ET | 1811 | 7.3594 |
| 01:03 ET | 1762 | 7.35 |
| 01:06 ET | 1983 | 7.3583 |
| 01:08 ET | 2949 | 7.33 |
| 01:10 ET | 100 | 7.33 |
| 01:12 ET | 705 | 7.345 |
| 01:14 ET | 500 | 7.345 |
| 01:15 ET | 2042 | 7.34 |
| 01:17 ET | 1241 | 7.35 |
| 01:21 ET | 100 | 7.35 |
| 01:24 ET | 2641 | 7.34 |
| 01:26 ET | 8557 | 7.33 |
| 01:28 ET | 1053 | 7.32 |
| 01:30 ET | 600 | 7.33 |
| 01:33 ET | 2405 | 7.37 |
| 01:35 ET | 150 | 7.39 |
| 01:37 ET | 1206 | 7.37 |
| 01:42 ET | 200 | 7.37 |
| 01:44 ET | 200 | 7.37 |
| 01:46 ET | 100 | 7.375 |
| 01:48 ET | 2165 | 7.38 |
| 01:50 ET | 300 | 7.38 |
| 01:51 ET | 200 | 7.385 |
| 01:53 ET | 1000 | 7.395 |
| 01:55 ET | 1375 | 7.39 |
| 01:57 ET | 1300 | 7.405 |
| 02:00 ET | 231 | 7.41 |
| 02:02 ET | 1574 | 7.41 |
| 02:04 ET | 800 | 7.425 |
| 02:06 ET | 1155 | 7.42 |
| 02:08 ET | 1750 | 7.4209 |
| 02:09 ET | 1464 | 7.4134 |
| 02:13 ET | 1460 | 7.41 |
| 02:15 ET | 27967 | 7.385 |
| 02:18 ET | 5108 | 7.37 |
| 02:20 ET | 4989 | 7.38 |
| 02:22 ET | 3931 | 7.408 |
| 02:26 ET | 5337 | 7.405 |
| 02:27 ET | 1500 | 7.41 |
| 02:29 ET | 200 | 7.415 |
| 02:31 ET | 3239 | 7.42 |
| 02:33 ET | 916 | 7.43 |
| 02:36 ET | 20458 | 7.46 |
| 02:38 ET | 13723 | 7.41 |
| 02:40 ET | 878 | 7.4 |
| 02:42 ET | 5800 | 7.425 |
| 02:44 ET | 752 | 7.425 |
| 02:45 ET | 1100 | 7.425 |
| 02:47 ET | 1450 | 7.435 |
| 02:49 ET | 4660 | 7.445 |
| 02:51 ET | 903 | 7.43 |
| 02:54 ET | 1445 | 7.43 |
| 02:56 ET | 787 | 7.435 |
| 02:58 ET | 555 | 7.435 |
| 03:00 ET | 600 | 7.45 |
| 03:02 ET | 2035 | 7.445 |
| 03:03 ET | 1900 | 7.46 |
| 03:05 ET | 4097 | 7.48 |
| 03:07 ET | 7597 | 7.485 |
| 03:09 ET | 1174 | 7.495 |
| 03:12 ET | 1403 | 7.49 |
| 03:14 ET | 100 | 7.485 |
| 03:16 ET | 5681 | 7.485 |
| 03:18 ET | 9013 | 7.485 |
| 03:20 ET | 10101 | 7.455 |
| 03:21 ET | 2724 | 7.465 |
| 03:23 ET | 1300 | 7.475 |
| 03:25 ET | 6273 | 7.48 |
| 03:27 ET | 1777 | 7.4777 |
| 03:30 ET | 7042 | 7.49 |
| 03:32 ET | 5016 | 7.465 |
| 03:34 ET | 7152 | 7.465 |
| 03:36 ET | 2500 | 7.475 |
| 03:38 ET | 11195 | 7.465 |
| 03:39 ET | 900 | 7.465 |
| 03:41 ET | 5332 | 7.505 |
| 03:43 ET | 6813 | 7.495 |
| 03:45 ET | 6871 | 7.485 |
| 03:48 ET | 2849 | 7.48 |
| 03:50 ET | 5401 | 7.505 |
| 03:52 ET | 11721 | 7.51 |
| 03:54 ET | 14719 | 7.495 |
| 03:56 ET | 10744 | 7.53 |
| 03:57 ET | 29879 | 7.545 |
| 03:59 ET | 192087 | 7.56 |
Sep 10, 2024
Vir Biotechnology Appoints Jason O'Byrne as Chief Financial Officer, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones*DJ Vir Biotechnology Appoints Jason O'Byrne As Chief Financial Officer >VIR, from 8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
8:05AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 9, 2024
Sep 4, 2024
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031, from 8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
8:30AM ET on Wednesday Sep 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vir Biotechnology Inc | 1.0B | -2.1x | --- |
Prothena Corporation PLC | 899.7M | -16.5x | --- |
Zymeworks Inc | 891.6M | -8.1x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -4.4x | --- |
Gyre Therapeutics Inc | 1.2B | -14.2x | --- |
WAVE Life Sciences Ltd | 1.2B | -14.3x | --- |
Company Information
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Contact Information
- Headquarters
- 1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
- Phone
- 415-906-4324
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Vicki Sato
- Chief Executive Officer, Director
- Marianne De Backer
- Executive Vice President, Chief Technology Officer
- Ann Hanly
- Executive Vice President, Chief Scientific Officer
- Jennifer Towne
- Executive Vice President and Chief Business Officer
- Jeffrey Calcagno
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
|---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 13.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
